clinical pharmacology and therapeutics

Rank: Unranked / 33517
Indexings
ncbi
Short Name clin pharmacol ther
Abbreviated Name clin pharmacol ther
ISSN 1532-6535
Aim and Scope
URL
Author Instructions

Publications Per Year

Top 10 Most Viewed Articles (11 total)

2020
Development of a System for Post-marketing Population Pharmacokinetic and Pharmacodynamic Studies using Real-World Data from Electronic Health Records.
Choi, Leena;Beck, Cole;McNeer, Elizabeth;Weeks, Hannah L;Williams, Michael L;James, Nathan T;Niu, Xinnan;Abou-Khalil, Bassel W;Birdwell, Kelly A;Roden, Dan M;Stein, C Michael;Bejan, Cosmin A;Denny, Joshua C;Van Driest, Sara L;
315 views DOI Abstract
2020
Challenges in Alzheimer Disease Drug Discovery and Development: The Role of Modeling, Simulation and Open Data.
Conrado, Daniela J;Duvvuri, Sridhar;Geerts, Hugo;Burton, Jackson;Biesdorf, Carla;Ahamadi, Malidi;Macha, Sreeraj;Hather, Gregory;Morales, Juan Francisco;Podichetty, Jagdeep;Nicholas, Timothy;Stephenson, Diane;Trame, Mirjam;Romero, Klaus;Corrigan, Brian;, ;
314 views DOI Abstract
2020
Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19.
Damle, Bharat;Vourvahis, Manoli;Wang, Erjian;Leaney, Joanne;Corrigan, Brian;
307 views DOI Abstract
2002
The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
Siegmund, Werner;Ludwig, Karen;Giessmann, Thomas;Dazert, Peter;Schroeder, Eike;Sperker, Bernhard;Warzok, Rolf;Kroemer, Heyo K;Cascorbi, Ingolf;
Vol. 72 , No. 5 , pp. 572-83
302 views Abstract
2019
Model-informed dose selection for Xentuzumab, a dual insulin-like growth factor-I/II -neutralizing antibody.
Parra-Guillen, Zinnia P;Schmid, Ulrike;Janda, Alvaro;Freiwald, Matthias;Troconiz, Iñaki F;
284 views DOI Abstract
2020
MID3: Mission Impossible or Model-Informed Drug Discovery and Development? Point-Counterpoint Discussions on Key Challenges.
Krishnaswami, Sriram;Austin, Daren;Della Pasqua, Oscar;Gastonguay, Marc R;Gobburu, Jogarao;van der Graaf, Piet H;Ouellet, Daniele;Tannenbaum, Stacey;Visser, Sandra A G;
261 views DOI Abstract
2019
Can Insights From Placebo and Nocebo Mechanism Studies Help Improve Randomized Controlled Trials?
Vase, Lene;
247 views DOI
2002
Effect of levothyroxine administration on intestinal P-glycoprotein expression: consequences for drug disposition.
Siegmund, Werner;Altmannsberger, Stephan;Paneitz, Andrea;Hecker, Ute;Zschiesche, Michael;Franke, Gerd;Meng, Wieland;Warzok, Rolf;Schroeder, Eike;Sperker, Bernhard;Terhaag, Bernd;Cascorbi, Ingolf;Kroemer, Heyo K;
Vol. 72 , No. 3 , pp. 256-64
231 views Abstract
2020
Target adverse event profiles for predictive safety in the post-market setting.
Schotland, Peter;Racz, Rebecca;Jackson, David B;Soldatos, Theodoros G;Levin, Robert;Strauss, David;Burkhart, Keith;
203 views DOI Abstract
2020
Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2
Thakur A;Tan SPF;Chan JCY;;
, pp. -
196 views Abstract
View All 11 Articles